Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/15/21 17:53 | 11/15/21 | EBS | Health | Drug | Pharmaceutical Preparations | Lindahl Richard S | MD | O | EVP,CFO | P | 112 | 37.46 | 0 | 3 | 8 | 40 | D | ||||||||||||||
6/2/15 16:47 | 6/1/15 | EBS | Health | Drug | Pharmaceutical Preparations | Havey Adam | MD | O | EVP,Biod | P | 3 | 27.08 | 8 | 0 | 0 | 41 | D | 120 | 45 | 26 | 4 | 5 | 1 | 0 | 1 | 2 | 2 | 5 | 10 | 23 | 40 |
12/9/13 10:26 | 11/30/13 | EBS | Health | Drug | Pharmaceutical Preparations | Abdun-Nabi Daniel | MD | DO | CEO | P | 14 | 19.08 | 3 | 1 | 1 | 103 | D | 28 | 47 | 50 | 24 | 16 | 8 | 1 | 2 | -2 | 1 | 8 | 20 | 1 | 14 |
6/4/13 16:21 | 5/31/13 | EBS | Health | Drug | Pharmaceutical Preparations | Abdun-Nabi Daniel | MD | DO | CEO | P | 10 | 12.07 | 2 | 1 | 1 | 96 | D | -43 | -5 | -10 | -8 | -6 | -1 | 0 | 1 | 0 | 7 | 7 | 24 | 58 | 50 |
5/21/07 15:41 | 5/18/07 | EBS | Health | Drug | Pharmaceutical Preparations | Zink Thomas | MD | O | SVP,CMO | P.m | 10 | 10.50 | 1 | 1 | New | 1 | D | -30 | -19 | -20 | -15 | -1 | 2 | 7 | -7 | -19 | -54 | -15 | |||
11/21/06 17:19 | 11/20/06 | EBS | Health | Drug | Pharmaceutical Preparations | Elsey R Don | MD | O | VP Finan | P.d | 3 | 11.45 | 9 | 0 | New | 0 | D | -3 | -2 | -5 | 3 | 26 | -1 | -53 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |